This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jan. 31, 2013

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Please click here to view Eisai's 2012 Oncology Digest. The PDF contains two articles and the final oncology digest.

Please click here to view the webcast on Eisai's 2012 Oncology Digest from the Fall Managed Care Forum.

Register today
Spring Managed Care Forum
May 2-3, 2013
Gaylord Palms
Orlando, Fla.

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts

Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.



Scientists find genetic clue to severe flu among Chinese
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
British and Chinese scientists have found a genetic variant which explains why Chinese populations may be more vulnerable to the H1N1 virus, commonly known as swine flu. The discovery of the variant could help doctors find those people at high risk of severe flu and prioritize them for treatment, researchers said. More

Couples offered DNA test for red hair gene
The Telegraph    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Couples are going to be offered a DNA test to see whether they carry the "ginger gene" giving them a chance of producing red-headed children. Using a simple saliva test, experts will search people's DNA for any of three common variants in the MC1R gene which are responsible for red hair color. More

Breast cancer gene may be tied to early menopause
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Women with the BRCA gene, who are already at greater risk for breast and ovarian cancer, may also be at increased risk for early menopause, according to a new study. Researchers found a harmful mutation in the BRCA gene may give women fewer childbearing years and may also increase their risk of infertility. And heavy smokers who carry the mutation may go through menopause even earlier than nonsmoking women with the mutation. More

 Biotech/Diagnostics/Personalized Medicine

Personalized regulation: Urgently needed in personalized medicine
Forbes    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Regulators of medical research face the daunting task of vetting protocols, drugs and devices to ensure that they are appropriate, meaning that the benefit/risk is reasonable. Understandably, there has been considerable focus on better defining both the benefit and the risk here, an effort that has paralleled the focus on "personalized medicine" — the right medicine for the right patient at the right time. More

Earn your MS in Nursing Online

Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies. These programs are designed to help the next generation of nursing leaders achieve their career goals while improving the health and well-being of all people. MORE

Genetic sequencing appears key to personalized medicine in pediatrics
Endocrine Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Modern genomics in the form of next-generation sequencing and exome sequencing will be commonplace in the Canadian pediatric endocrine clinic in the near future, according to Kym Boycott. The use of genomic technologies might indicate a different therapy for several rare, pediatric endocrine conditions than would a standard management approach, Boycott said. More

Men, women respond differently to drug dosages
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Most sleeping pills are designed to knock you out for eight hours. When the Food and Drug Administration was evaluating a new short-acting pill for people to take when they wake up in the middle of the night, agency scientists wanted to know how much of the drug would still be in users' systems come morning. Blood tests uncovered a gender gap: Men metabolized the drug, Intermezzo, faster than women. Ultimately the F.D.A. approved a 3.5 milligram pill for men, and a 1.75 milligram pill for women. More

 Regenerative Medicine

Stem cells may aid Parkinson's treatment
San Francisco Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
There is much excitement in the medical profession about how stem-cell-based therapies could someday affect how Parkinson's disease is treated. Parkinson's disease is a neurological disorder caused by the dying off of a certain type of brain cells. These cells are located in the midbrain of the brainstem in an area called the substantia nigra. More

Saving lives with help from pigs and cells
The Houston Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A pioneer in regenerative medicine research and cell therapy, Doris Taylor recently arrived at the Texas Heart Institute. Taylor came from the University of Minnesota, where she won international attention for her work with "whole-organ decellularization" — removing the existing cells from the hearts of lab animals and humans to leave a framework to build new organs. More

Eye-opener as scientists grow lens cells
The Age    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have established a way to grow human eye lens cells in the laboratory — the first time this has been done at 100 percent purity. The discovery means patients suffering congenital sight impairment caused by lens damage such as cataracts might one day be able to have a transplant, allowing them to grow an eye lens without the genetic defects their DNA would otherwise dictate. More

 Emerging Medical Technologies

Survey: Implanted defibrillator patients prefer device off if very ill
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Most heart patients with implantable cardioverter-defibrillators would prefer to switch off the device if they had an advanced illness, new research suggests. Researchers said the findings contrast with earlier surveys of patients with implantable defibrillators that showed most didn't want their devices deactivated. More

Discover the Concentra Difference.

Concentra offers medical practice expertise, operational and peer support, and long-term stability to enable your professional and financial success. Our providers work consistent schedules that encourage healthy work-life balance, and experience the satisfaction of working in an environment designed to reduce administrative burden while allowing more time for patient care.

Experiment tests how humans relate to machines
NPR    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefMany people have studied machine-human relations, and at this point it's clear that without realizing it, we often treat the machines around us like social beings. One study demonstrated that people do obey the rule of reciprocity when it comes to computers. When the first computer was helpful to people, they helped it way more on the boring task than the other computer in the room. They reciprocated. More

 Managed Healthcare News

Managed care tax key in California's Healthy Families shortfall
California Healthline    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Healthy Families program is short by almost $100 million, according to California health officials. That number will rise, officials said, because the current deficit only covers the program's operation for January and half of December. More

Did health insurance industry help shove CO-OPs off fiscal cliff?
AIS Health    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The number of Consumer Operated and Oriented Plans is unlikely to ever exceed 24 due to a last-minute deal struck by lawmakers to avoid pushing the economy over the so-called "fiscal cliff." Going over the cliff instead are groups that had applied to operate as CO-OPs but hadn't yet received approval from HHS. The organization representing the fledgling entities contends a nervous health insurance industry is behind the funding cut. More

 FDA: New Treatments and Technology

Nondrug ADHD treatments don't pan out in study
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Many parents pursue costly and time-consuming treatments to help their children with attention-deficit/hyperactivity disorder. Now, a new study finds little evidence that nondrug interventions reduce key symptoms of ADHD. More

FDA likely to add limits to painkillers
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Trying to stem the scourge of prescription drug abuse, an advisory panel of experts to the Food and Drug Administration voted to toughen the restrictions on painkillers like Vicodin that contain hydrocodone, the most widely prescribed drugs in the country. More

"Children who suffer from ADHD can be easily distracted, fidget, talk nonstop and struggle following instructions, according to the National Institutes of Health."


Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Jan. 31, 2013
Jan. 24, 2013
Jan. 17, 2013
Jan. 10, 2013

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063